That's great Sidepocket, so if you know that Pharma's can't switch over to LymPro very quickly, and you're not even a biotech CEO, why didn't Gerald know that when he said "LymPro revenue will change the math?" He said we'd get a "significant portion of the 150 million RUO market" in 2015. Either he lied or was grossly uninformed. Didn't he talk to Pharmas before he made those statements so he'd have a better handle on things?To see Gerald's comments about LymPro without ascribing any blame to him......is sugarcoating it.
I don't want our CEO manipulating us!! I want him to tell the truth.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links